Similar articles

• Delayed cutaneous hypersensitivity in children with severe multiple handicaps treated with phenytoin.

  Higashi A, Matsuda I, Sinosuka S, Ohtsuka H, Endo F, Maeda T, Ikeda T, Miyoshino S. Higashi A, et al. Eur J Pediatr. 1978 Dec 1;129(4):273-8. doi: 10.1007/BF00441358. Eur J Pediatr. 1978. PMID: 152707
• Letter: Lymphocyte-count in children treated with phenytoin.

  Higashi A, Ikeda T, Adaboshi I, Karashima S, Miike T. Higashi A, et al. Lancet. 1976 Jul 3;2(7975):44. doi: 10.1016/s0140-6736(76)92999-8. Lancet. 1976. PMID: 59106 No abstract available.
• [Changes in the serum immunoglobulins levels induced by phenytoin in epileptic children].

  Talesnik E, Rivero S, González B. Talesnik E, et al. Rev Chil Pediatr. 1985 Mar-Apr;56(2):76-80. Rev Chil Pediatr. 1985. PMID: 4089271 Spanish. No abstract available.
• Serum IgA deficiency induced by prolonged phenytoin treatment.

  Talesnik E, Rivero SJ, González B. Talesnik E, et al. Rev Invest Clin. 1989 Oct-Dec;41(4):331-5. Rev Invest Clin. 1989. PMID: 2631168
• Predictability of unbound antiepileptic drug concentrations in children treated with valproic acid and phenytoin.

  Miles MV, Snead OC 3rd, Thorn MD. Miles MV, et al. Clin Pharm. 1988 Sep;7(9):688-93. Clin Pharm. 1988. PMID: 3149223 No abstract available.